Matches in Wikidata for { <http://www.wikidata.org/entity/Q37149390> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q37149390 description "article científic" @default.
- Q37149390 description "article scientifique" @default.
- Q37149390 description "articolo scientifico" @default.
- Q37149390 description "artigo científico" @default.
- Q37149390 description "artículu científicu espublizáu en 2015" @default.
- Q37149390 description "bilimsel makale" @default.
- Q37149390 description "scientific article published on 27 August 2015" @default.
- Q37149390 description "vedecký článok" @default.
- Q37149390 description "vetenskaplig artikel" @default.
- Q37149390 description "videnskabelig artikel" @default.
- Q37149390 description "vědecký článek" @default.
- Q37149390 description "wetenschappelijk artikel" @default.
- Q37149390 description "wissenschaftlicher Artikel" @default.
- Q37149390 description "наукова стаття, опублікована в серпні 2015" @default.
- Q37149390 description "научни чланак" @default.
- Q37149390 description "مقالة علمية نشرت في 27 أغسطس 2015" @default.
- Q37149390 name "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 name "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 name "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 type Item @default.
- Q37149390 label "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 label "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 label "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 prefLabel "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 prefLabel "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 prefLabel "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia." @default.
- Q37149390 P1433 Q37149390-9A432D30-5D0D-4A24-8C7B-70656F214DE6 @default.
- Q37149390 P1476 Q37149390-E5B3E03F-AB85-478C-96CF-9B57C24FBFE0 @default.
- Q37149390 P2093 Q37149390-C0B9A1D6-02EF-4315-BC3E-7F219CCEE5DD @default.
- Q37149390 P2860 Q37149390-13F65B5C-EF70-4138-ACCF-1AC7FAC3C0D6 @default.
- Q37149390 P2860 Q37149390-24CFD0C9-DBA3-42D7-AB75-DF9A1D3F2032 @default.
- Q37149390 P2860 Q37149390-3DAE525A-8C8E-40EA-AEF4-C2182BD0DD23 @default.
- Q37149390 P2860 Q37149390-46D0B69F-D85B-4E7F-97F5-3E1B306A2604 @default.
- Q37149390 P2860 Q37149390-5FCDC6A2-1487-4410-9E1F-7F4F15B2BE51 @default.
- Q37149390 P2860 Q37149390-9DE50EFF-B2E1-4686-9327-43CF52114AB5 @default.
- Q37149390 P2860 Q37149390-B48D6548-D226-41B3-8442-AD1DBCBB857A @default.
- Q37149390 P2860 Q37149390-C848A523-9108-41BD-9FC4-85C7DB06C955 @default.
- Q37149390 P2860 Q37149390-F5CCBEFF-D3A2-420C-88E9-30F97E87EDB9 @default.
- Q37149390 P2860 Q37149390-F97494B8-26BE-4BFA-8E33-AD672BF9A155 @default.
- Q37149390 P304 Q37149390-2A795447-89F1-4592-BF74-9BBB07E16049 @default.
- Q37149390 P31 Q37149390-FA4BD677-45D5-46EB-A625-9B6FD620C4E9 @default.
- Q37149390 P356 Q37149390-C02F1DBF-CE3F-4477-B117-9EB25BC4CAED @default.
- Q37149390 P433 Q37149390-2FEBA4AC-FDE3-49CD-BF4D-91C8174BC683 @default.
- Q37149390 P478 Q37149390-E57DB39D-830E-43AF-869F-2A0105630671 @default.
- Q37149390 P50 Q37149390-26F59369-D593-4766-B412-43E31BFE55C2 @default.
- Q37149390 P577 Q37149390-E97CEE54-32C4-4D39-8AB6-EF1161CB821C @default.
- Q37149390 P698 Q37149390-53A86707-CC12-47A2-AE57-4E88355237EA @default.
- Q37149390 P921 Q37149390-DCBCD06E-3ECC-44B1-A9CF-AA8728AB3DBA @default.
- Q37149390 P932 Q37149390-0AC64EC5-F9BD-4B83-AAF3-EB51061BFB87 @default.
- Q37149390 P356 23723556.2015.1071303 @default.
- Q37149390 P698 27652311 @default.
- Q37149390 P1433 Q27725948 @default.
- Q37149390 P1476 "Co-activation of AMPK and mTORC1 as a new therapeutic option for acute myeloid leukemia" @default.
- Q37149390 P2093 "Pierre Sujobert" @default.
- Q37149390 P2860 Q24634174 @default.
- Q37149390 P2860 Q28268061 @default.
- Q37149390 P2860 Q29620878 @default.
- Q37149390 P2860 Q37543714 @default.
- Q37149390 P2860 Q38424822 @default.
- Q37149390 P2860 Q42436880 @default.
- Q37149390 P2860 Q42953330 @default.
- Q37149390 P2860 Q45154681 @default.
- Q37149390 P2860 Q50273440 @default.
- Q37149390 P2860 Q53120111 @default.
- Q37149390 P304 "e1071303" @default.
- Q37149390 P31 Q13442814 @default.
- Q37149390 P356 "10.1080/23723556.2015.1071303" @default.
- Q37149390 P433 "4" @default.
- Q37149390 P478 "3" @default.
- Q37149390 P50 Q48282150 @default.
- Q37149390 P577 "2015-08-27T00:00:00Z" @default.
- Q37149390 P698 "27652311" @default.
- Q37149390 P921 Q29496 @default.
- Q37149390 P932 "4972110" @default.